Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|June 9, 2023
Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in miceDavid R Martinez, Alexandra Schafer, Tyler D Gavitt, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.Nature Communications|November 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.Biorxiv : the Preprint Server for Biology|August 17, 2021
Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticlesZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.Cell Reports|October 20, 2023
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.Biorxiv : the Preprint Server for Biology|December 23, 2024
Structural and antigenic characterization of novel and diverse Henipavirus glycoproteinsAaron J May, Muralikrishna Lella, Jared Lindenberger, et al.Journal of Virology|August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designsZekun Mu, Jill Whitley, Diana Martik, et al.Cell Reports|March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.Science Translational Medicine|January 8, 2025
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutationsOlivia M Swanson, Qianyi E Zhang, Elizabeth Van Itallie, et al.Cell Reports|December 28, 2017
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal ModelsKevin O Saunders, Laurent K Verkoczy, Chuancang Jiang, et al.Pageof 3